ETOPOSIDE (VP16-213) - A PODOPHYLLOTOXIN-DERIVATIVE WITH HIGH ANTI-TUMOR ACTIVITY

被引：21
作者：
SCHMOLL, HJ
NIEDERLE, N
ACHTERRATH, W
机构：
[1] HANOVER UNIV MED, DEPT INNERE MED, D-3000 HANOVER, FED REP GER
[2] UNIV ESSEN GESAMTHSCH, INNERE KLIN & POLIKLIN WESTDEUTSCH TUMOR ZENTRUM, D-4300 ESSEN, FED REP GER
[3] BRISTOL MYERS GMBH, KLIN FORSCH ZYTOSTATIKA ABT, NEU ISENBURG, FED REP GER
来源：
KLINISCHE WOCHENSCHRIFT | 1981年 / 59卷 / 21期
关键词：
D O I：
10.1007/BF01721212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1177 / 1188
页数：12
相关论文
共 146 条
[1]  
AHMANN DL, 1976, CANCER TREAT REP, V60, P633
[2]  
AISNER J, 1980, P AM ASSOC CANC RES, V21, P453
[3]  
AISNER J, 1980, 2ND WORLD C LUNG CAN, P139
[4]  
ALLEN LM, 1976, P AM ASSOC CANC RES, V17, P6
[5]   COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES [J].
ALLEN, LM ;
CREAVEN, PJ .
EUROPEAN JOURNAL OF CANCER, 1975, 11 (10) :697-707
[6]  
ARNOLD AM, 1979, CANCER CHEMOTH PHARM, V3, P71
[7]   CELL-CYCLE STAGE-DEPENDENT INDUCTION OF G2 PHASE ARREST BY DIFFERENT ANTI-TUMOR AGENTS [J].
BARLOGIE, B ;
DREWINKO, B .
EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) :741-745
[8]  
BENDER R A, 1978, P77
[9]   ANTI-NEOPLASTIC DRUGS - CLINICAL PHARMACOLOGY AND THERAPEUTIC USE [J].
BENDER, RA ;
ZWELLING, LA ;
DOROSHOW, JH ;
LOCKER, GY ;
HANDE, KR ;
MURINSON, DS ;
COHEN, M ;
MYERS, CE ;
CHABNER, BA .
DRUGS, 1978, 16 (01) :46-87
[10]  
BENDER RA, 1979, CANCER CHEMOTHERAPY, P93
12345678910